Phenyl pyridin-3-ylcarbamate → 4-[3-(benzyloxy)benzylidene]-N-pyridin-3-ylpiperidine-1-carboxamide

関与物質

反応手順

Following the procedure in Example 1, Step 6, 4-(3-benzyloxy-benzylidene)-piperidine trifluoroacetate (550 mg, 1.4 mmol, from Step 3) and phenyl pyridin-3-ylcarbamate (331 mg, 1.55 mmol) were used to provide the title compound (530 mg). MS (APCI 10 V) AP+ 400.2; 1H NMR (400 MHz, CD3OD) δ ppm 2.40-2.46 (m, 2H) 2.46-2.52 (m, 2H) 3.48-3.54 (m, 2H) 3.60-3.66 (m, 2H) 5.08 (s, 2H) 6.40 (s, 1H) 6.76-6.89 (m, 3H) 7.22 (t, J=8.09 Hz, 1H) 7.26-7.46 (m, 5H) 7.86-7.95 (m, J=8.36, 2.48, 1.45, 0.89 Hz, 1H) 8.16 (dd, J=4.81, 1.40 Hz, 1H) 8.58 (d, J=2.53 Hz, 1H).

情報源と証拠